|
|
.
See Category: Diseases of the respiratory system
ICD-10 (CM) Code and Descriptor
|
J82.81 |
Chronic eosinophilic pneumonia
|
J8281 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.82%
|
19.76%
|
10.55%
|
5.61%
|
3.64%
|
2.85%
|
2.22%
|
1.05%
|
0.75%
|
1.17%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for J82.81*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
254
|
254
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
211
|
241
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
211
|
211
|
|
J2182
|
INJECTION, MEPOLIZUMAB, 1MG |
197
|
26,300
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
196
|
196
|
|
71250
|
CT THORAX DX C- |
121
|
121
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
114
|
114
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
105
|
105
|
|
94729
|
CO/MEMBANE DIFFUSE CAPACITY |
95
|
95
|
|
80053
|
COMPREHEN METABOLIC PANEL |
62
|
62
|
|
94726
|
PULM FUNCT TST PLETHYSMOGRAP |
56
|
56
|
|
94060
|
EVALUATION OF WHEEZING |
52
|
52
|
|
J3370
|
VANCOMYCIN HCL INJECTION |
50
|
461
|
|
94010
|
BREATHING CAPACITY TEST |
49
|
49
|
|
96366
|
THER/PROPH/DIAG IV INF ADDON |
49
|
98
|
|
J7040
|
NORMAL SALINE SOLUTION INFUS |
46
|
116
|
|
J0517
|
INJ., BENRALIZUMAB, 1 MG |
45
|
1,350
|
|
80048
|
METABOLIC PANEL TOTAL CA |
45
|
45
|
|
82785
|
ASSAY OF IGE |
45
|
45
|
|
97530
|
THERAPEUTIC ACTIVITIES |
43
|
59
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
J82.81 related to the following DRG Codes:
196-198
|
